Bringing science to health and nutrition

ΔG™ is the first example of an entirely new food group that offers significant commercial opportunities in a wide range of complementary market areas.

This innovative nutraceutical has already shown promise in improving physical and cognitive performance in a wide range of environments, from sports track to battlefield. Studies are also underway to investigate the potential effects of ΔG™ in a range of clinical conditions.

The synthesis and manufacture of ΔG™ draws directly on pioneering research carried out at the University of Oxford and the National Institutes of Health.

With trials already at an advanced stage, ΔG™ has potential use in a wide range of commercial products that are set to reach the market as early as 2014. A global patent portfolio is currently being developed to protect ΔG™ and its manufacture as well as its areas of application.

Learn more about this unique investment opportunity with dramatic upside potential